Operator
Good morning, and welcome to InRetail Perú's Third Quarter 2026 Conference Call. [Operator Instructions] And please note that this call is being recorded.
[Operator Instructions] Before we begin, I would like to remind you that today's call is for investors and analysts only. Therefore, questions from the media will not be taken.
Joining us today from InRetail Perú are Mr. Juan Carlos Vallejo, Chief Executive Officer; Mr.
Marcelo Ramos, Chief Financial Officer; and Mrs. Andrea Fabbri, Investor Relations Officer.
They will be discussing the quarterly report distributed by the company yesterday, November 12. If you have not yet received a copy of the earnings report, please visit www.inretail.pe on the Investors section, where there is also a webcast presentation to accompany the discussion during this call.
If you need any assistance, please contact the Investor Relations team of InRetail Perú. Please be advised that forward-looking statements may be made during this conference call, and they do not account for economic circumstances, industry conditions, the company's performance or financial results.
As such, these forward-looking statements are based in several assumptions and factors that could change causing actual results to differ materially from the current expectations. For a complete note on the forward-looking statements, please refer to the quarterly report, which was issued yesterday.
At this point, I would like to turn the call over to Mr. Juan Carlos Vallejo, Chief Executive Officer of InRetail Perú for his opening remarks.
Mr. Vallejo, please go ahead, sir.
Juan Blanco
Thank you, Paul. Good morning, everyone.
This is Juan Carlos Vallejo, Chief Executive Officer of InRetail, and thank you for joining our third quarter 2026 earnings call. Today, we will review the main highlights of our performance during the quarter.
I'm joined today by Marcelo Ramos, our Chief Financial Officer; Andrea Fabbri, our Investor Relations Officer. I will open with a brief executive overview, after which Marcelo will review our earnings presentation in detail.
During the third quarter, the Peruvian economy maintained its positive trajectory, underpinned by strong domestic demand. On the political front, the new administration has completed its first months in office amid a more stable environment.
Inflation has picked up over the course of the year and has proven more persistent than initially expected. While the exchange rates have remained relatively stable, we saw only a slight depreciation of the sol during the quarter, mainly driven by external factors.
In addition, early effects of the El Niño phenomenon are beginning to be felt in certain primary sectors, such as fishing and agriculture as well in specific consumption categories, mainly as a result of warmer-than-usual temperatures. Overall consumption, however, has remained resilient.
InRetail once again leveraged the strength of our multi-format platform to capture solid domestic demand and reinforce our leadership across segments. Our strategic agenda also continued to progress.
Over the last 12 months, we added 157 net new Hard Discount stores and 3 supermarkets as well as 99 net new Pharmacies. At the same time, we continue to enhance our value proposition across formats and expand our logistic capabilities.
Turning now to our financial results. Consolidated revenue reached approximately PEN 6.3 billion in Q3 '26, up 11.6% year-over-year, driven by double-digit growth in Food Retail and Shopping Malls.
Consolidated adjusted EBITDA rose 8.8% to PEN 831 million, led by Pharma and Shopping Malls, while Food Retail grew at a more moderate pace. Food Retail revenue grew 15.1% with same-store sales up 11.6%.
Adjusted EBITDA grew 5.8% as gross margin expansion was partially offset by higher logistics and energy costs as well as a high comparison base that includes one-off income in Q3 '25. Pharma revenue grew 5.2%, driven by our core pharmacy unit, which grew 9.5% with same-store sales up 7.1%, partially offset by a high comparison base in distribution.
Adjusted EBITDA for the segment grew 9.6%. Shopping Malls delivered another strong quarter with revenue up 15.9% and adjusted EBITDA up 16.2%, while occupancy remained high at 95.7%.
Notably, the segment's LTM adjusted EBITDA has already surpassed its full year 2024 level. Looking ahead to full year 2026, we are raising our revenue guidance to low double-digit growth and maintain our guidance of low double-digit growth in adjusted EBITDA.
I will now turn the call over to Marcelo, and we look forward to taking your questions following the presentation.
Marcelo Ramos
Thank you, Juan Carlos. Good morning, everyone, and thank you for joining us today.
I will now walk you through our financial and operating performance for the third quarter of 2026 in greater detail. Let us start with our consolidated financial results on Page 4 of the presentation.
Unless otherwise noted, all growth rates and comparisons refer to the third quarter of 2026 versus the third quarter of 2025. InRetail delivered another quarter of strong line -- top line momentum as our multi-format platform allows us to capitalize on a supportive consumption environment and further strengthen our leadership position across segments.
Consolidated revenues reached approximately PEN 6.3 billion, up 11.6%. This performance was driven by double-digit growth in Food Retail and Shopping Malls of 15.1% and 15.9%, respectively, complemented by 5.2% growth in Pharma, where our core Pharmacies grew 9.5%.
Adjusted EBITDA reached PEN 831 million, up 8.8% with an adjusted EBITDA margin of 13.3% compared to 13.6% in Q3 '25. Growth was led by Pharma and Shopping Malls, up 9.6% and 16.2%, respectively, while Food Retail grew 5.8%, reflecting temporarily higher energy and logistic costs, which also affected our other business units as well as a high comparison base that I will address in more detail in the segment review.
As anticipated in our previous earnings call, during the quarter, we faced temporary expense pressures, mainly from higher electricity tariffs, which increased sharply from July onwards and primarily affected our Food Retail and Shopping Malls segments. In addition, consistent with prior quarters, we incurred incremental logistics and transportation expenses associated with our new distribution centers and higher average fuel prices.
To address these pressures, we continue to identify and implement operational efficiencies across all of our business units. On the electricity cost front, we have already secured a long-term energy contract to mitigate this volatility moving forward.
These efforts allowed our segments to partially mitigate these pressures and demonstrate operational resilience. Please turn to Page 5 to review our consolidated net income results.
Net income reached PEN 201 million, 16.7% below Q3 '25 with net margin at 3.2% compared to 4.3% in Q3 '25. The PEN 67 million increase in adjusted EBITDA was more than offset by below line items, mainly a negative FX effect of PEN 79 million as the sol depreciated during the quarter compared to an appreciation of Q3 '25.
This is a non-cash effect arising from our U.S. dollar-denominated liabilities, including lease liabilities recognized under IFRS 16.
Additionally, we recorded higher depreciation and amortization of PEN 21 million and higher net financial expenses of PEN 17 million, partially offset by a positive mark-to-market effect of PEN 11 million. Net income also reflects our 50% share of a PEN 37 million precautionary provision recorded by InFinance XP in anticipation of potential effects from the El Niño phenomenon, consistent with what other financial institutions are doing in the country.
Excluding FX and mark-to-market effects, net of taxes, adjusted net income grew 3.4% to PEN 223 million with a margin of 3.6%. Further excluding our share of the precautionary provisions at InFinance XP, net of taxes, adjusted net income would have grown approximately 10% to PEN 236 million, better reflecting the performance of our operations.
On Page 6, you will find our year-to-date cash flow breakdown. We closed the quarter with a cash position of PEN 1.5 billion, in line with Q3 '25, but below the PEN 1.9 billion reported at year-end 2025.
Operating cash flow reached PEN 1.5 billion in the first 9 months, which together with net financial debt inflows of PEN 238 million funded CapEx, lease payments, financial expenses and distribution to shareholders. Year-to-date, we executed 2 nonrecurring transactions that resulted in cash outflows, our share buyback program of PEN 100 million and the PEN 65 million payment to complete our acquisition of a 50% stake in InFinance XP.
Excluding these 2 transactions, our cash balance would have been approximately PEN 2 billion, slightly above our year-end 2025 balance and well above Q3 '25. CapEx for the first 9 months of 2026 totaled PEN 578 million, with Food Retail accounting for approximately 45%, Shopping Malls for around 30% and Pharma for the remaining.
Most of this investment was directed to growth, including new store openings, land bank acquisitions, store renovations and expansions, while the balance went to maintenance and to other logistics and IT investments. As noted last quarter, year-to-date, CapEx was below 9 months 2025 levels given the high comparison base last year when we made significant investments in our new Pharma distribution center and land bank acquisitions in the first months of the year.
Moving to Page 7, let me cover our financial debt and leverage. Consolidated net leverage stood at 1.8x at the end of the quarter, down from 2.0x in Q3 '25 and stable quarter-over-quarter.
This was supported by adjusted EBITDA growth across our segments and a stable cash position despite the 2 nonrecurring outflows mentioned earlier. By issuer, InRetail Consumer reported a net leverage ratio of 1.4x, below Q3 '25 levels, reflecting a sustained deleveraging trend while we continue to fund our growth.
Meanwhile, InRetail Shopping Malls closed the quarter at 2.6x, down from 2.8x in Q2 '26 and from 3.4x in Q3 '25. This improvement reflects solid adjusted EBITDA growth, which more than offset the higher debt levels following the senior notes issuance last year.
Both issuers continue to show healthy leverage metrics, and we expect to close 2026 with consolidated net leverage below year-end 2025 levels. Our debt maturity profile remains comfortable with InRetail Consumer 2028 notes as the most significant upcoming maturity.
Page 8 provides the last 12 months overview by segment. Over the last 12 months, InRetail generated consolidated revenues of PEN 24.7 billion and adjusted EBITDA of PEN 3.3 billion with an adjusted EBITDA margin of 13.4%.
Notably, our Shopping Malls segment LTM adjusted EBITDA has already surpassed its full year 2024 level, confirming the segment's strong operational recovery and resilience. Moving on to segment results.
I will start with Food Retail on Page 10. Food Retail revenues grew 15.1% to PEN 3.6 billion in Q3 '26 as we captured the positive momentum -- in consumption momentum and further strengthened our leadership position in the sector.
All formats contributed to this growth, supported by solid demand across food and nonfood categories. Same-store sales grew 11.6% with double-digit growth in food and high single-digit growth in nonfood categories.
Same-store sales in our hard discount and Cash & Carry formats grew around 15%, while supermarkets posted a same-store sales growth of 8.3%, the latter supported by steady demand across categories, particularly fresh food. Cash & Carry and hard discount now represent 52.1% of Food Retail revenues.
Revenues were also benefited from these new stores opened over the last 12 months, including 157 net new Hard Discount stores and 3 new supermarkets, 2 Plaza Vea stores in the provinces and the reopening of 1 Vivanda store in Lima. Gross margin expanded to 23.9% from 23.4% with a flat commercial margin despite the growing weight of our emerging formats in the sales mix and favored by unrealized gains related to intercompany transactions within the Food Retail segment.
Adjusted EBITDA grew 5.8% to PEN 301 million, with margins at 8.4% compared to 9.2% in Q3 '25. This was impacted by higher logistic costs from the new distribution center supporting our hard discount expansion and higher fuel prices as well as higher energy costs mentioned earlier.
Results were also compared against a high base in Q3 '25, which included one-off income from the sales of non-operating land plot and business interruption insurance compensation, both adding to about PEN 11 million. Excluding these one-off incomes in the base, adjusted EBITDA for the segment would have grown closer to 10%.
In sum, Food Retail delivered robust top line growth this quarter, reflecting the strength of our competitive positioning, the differentiated value proposition of our multi-format platform and the tailored strategy we execute in each format. Let us now move to Pharma on Page 11.
Pharma revenues grew 5.2% to PEN 2.4 billion, driven by our core Pharmacies unit, which grew 9.5% and now represents 79% of segment revenues. Growth was tempered by distribution, where revenues declined 9.3% against a high comparison base as Q3 '25 still included sales from non-core channels we since exited.
We expect this effect to persist through the year. Pharmacy same-store sales grew 7.1% with similar growth in pharma and non-pharma categories, reflecting resilient consumer demand.
Pharma categories benefited from strong demand, particularly from antidiabetics and weight loss medications, including GLP-1 therapies, partially offset by lower sales in winter-related categories amid the warmer temperatures. Non-pharma categories were supported by our multi-format strategy.
As discussed in prior calls, this year, we had remodeled a number of existing stores to better capture high-growth complementary categories to respond to evolving customer needs and enhance the in-store experience. This strategy is allowing us to achieve strong revenue growth in personal care, beauty, dermocosmetics and vitamins and supplements, more than offsetting the decline in infant care from a generalized market slowdown.
Revenues were also benefited from the 99 net new stores opened over the last 12 months, including 56 in our Beauty & Personal Care formats through both new openings and conversions of existing stores. Segment gross margin expanded to 33.3%, driven by the higher share of Pharmacies in the revenue mix.
Adjusted EBITDA increased 9.6% to PEN 440 million, with margin expanding to 18.1% as a higher gross margin more than offset incremental expenses from the new stores opened and the ramp-up of our new distribution center. On Page 12, we present the results of our Shopping Malls segment.
Shopping Malls revenues increased 15.9% to PEN 217 million, driven by approximately 26,000 square meters of additional GLA, rent renewals and higher variable rent from stronger tenant sales as well as higher service income, mainly from the increased energy charges. Tenant same-store sales grew 7.3%, a slower pace than in prior quarters with solid performance across most categories, offset by softer apparel and footwear sales, which affected department stores and other tenants, given the milder-than-expected winter.
Occupancy remained high at 95.7%, underscoring the quality and relevance of our portfolio. Adjusted EBITDA rose 16.2% to PEN 126 million and net rental margin expanded 89 basis points to 79.5%.
Growth was mainly driven by higher rental and service income and a low comparison base that included one-off net expenses in Q3 '25, partially offset by lower service margins due to the higher energy and other utility costs. As anticipated in prior calls, the favorable comparison effects related to the 2025 incident mainly benefited the Shopping Malls segment's adjusted EBITDA during the first half of 2026.
These effects have now largely dissipated, and now we do not expect them to be material for the remaining of the year. Please turn to Page 13 for our key operating metrics.
In the third quarter, we continued to execute our strategic priorities with discipline, expanding our organic footprint, strengthening our value proposition across formats and building out our logistics platform. During the quarter, we added 22 net new Hard Discount stores and 29 net new Pharmacies, including 10 in our Beauty & Personal Care formats.
We also advanced the development of our new power center outside Lurín. By year-end, we expect to open now more than 100 Pharmacies across all formats and around 200 Hard Discount stores on a gross basis as well as one power center in the provinces, which will include one of our supermarkets.
To conclude, Q3 '26 demonstrated the strength of our multi-format platform as we continue to capitalize on positive consumption trends and further strengthen our leadership position across segments. While warmer temperatures since July have brought some early mild effects of El Niño phenomenon, temporarily affecting specific discretionary categories, we remain well positioned to navigate these challenges.
Our multi-format platform is highly resilient with the vast majority of our revenues generated in essential categories. And this is supported by a nationwide logistics network that is difficult to replicate.
This is further reinforced by our leading market positions and the solid balance sheet. Looking ahead, while El Niño and temporary cost pressures such as energy and payroll could weigh on results in the short term, the favorable consumption environment and a more stable political landscape provide a solid foundation for InRetail.
We are uniquely positioned to continue capitalizing on this positive economic cycle and delivering long-term value to our shareholders. Finally, regarding our full year 2026 guidance, as Juan Carlos mentioned earlier, we are raising our consolidated revenue guidance to low double-digit growth and reaffirming our adjusted EBITDA guidance of low double-digit growth.
This concludes our prepared remarks. We would now like to open the call for questions.
Operator
[Operator Instructions] At this time, there are no live questions coming through. I would like to hand it over to the -- for the webcast questions.
Andrea Fabbri
Thank you, operator. We have some questions from the webcast.
The first one is, could you explain if there should be more provisioning coming from InFinance XP in the coming quarters?
Marcelo Ramos
Sure. Thank you for the question.
So as I mentioned in the presentation, InFinance provisioned as a preventive measure, PEN 37 million, of which 50% applies to us given the share that we have in the company. So net of taxes is an effect of about PEN 12 million.
This is very much in line with what other financial institutions in the country have been doing. Based on what we know and what management knows as of today, assuming the latest news on El Niño, which is supposed to be an extraordinary El Niño, the management believes that the PEN 37 million should be enough.
So again, based on the information that we have as of today, we don't expect any additional provisions than the PEN 37 million that are already in [indiscernible].
Andrea Fabbri
I want to take the next question. You mentioned in the release about the renovation of hard discount stores.
Considering that the stores are relatively new, can you give some examples on what things are being changed at the store? And what is the performance increase and how diverse it is?
Marcelo Ramos
Sure. So this year, we renovated, I believe, more than this year, 340 stores.
In total, the stock of the renovated stores, I believe is around 700. Yes, many of the stores are new ones, but we also have stores that we opened some years ago.
And the renovations have to be basically in changing layouts. We're improving as well the infrastructure in some of the stores.
We're changing some of the refrigerators and some of the freezers and whatnot for the value proposition. The results, you see them in the same-store sales.
As we mentioned before, during the quarter, the same-store sales at around 15%, and that's a result as well of the stores that have been renovated over the last few -- couple of years or so.
Andrea Fabbri
Great. The next question, can you comment on any material change in sales trends in October and November?
Marcelo Ramos
So sales in October and November has been so far very similar to what we're seeing right now. The trends have been very similar, double-digit growth in retail, Pharmacies as well, closer to high single digit, close to the 10%.
So the trends have been actually pretty similar in October and November in terms of consumption and what we saw in the third and the second quarter.
Andrea Fabbri
Okay. The next question, have you seen any El Niño impact so far on Food Retail, Pharma or Shopping Malls, either in sales, store operations or logistics, any distribution center disruptions?
Marcelo Ramos
So far, we haven't seen -- other than what I mentioned in the presentation, we haven't seen anything else. The only impact that we saw is -- and you can see essentially in the Shopping Malls same-store sales of our tenants is given the warmer weather, some tenants being affected, particularly those in apparel and clothing and whatnot.
In the case of Pharma, for example, we did see a slowdown in certain cold and flu, namely winter-related categories, but that was more than offset by growth in other Pharma categories as well. So on a net, no effect on that business.
As it relates to logistics, nothing yet, to be honest. But as we mentioned in the call in Q2, the companies are preparing for El Niño.
At the end of the day, of course, for us, the potential impact that El Niño can have for us are supply chain -- mainly supply chain issues, road interruptions, the access to certain SKUs and whatnot. But again, it's not the first El Niño that we're going to go through.
I think we're very well positioned to transition during those periods. And we're making some investments in advance, particularly in inventory, for example, the Pharma business made some purchases in 3Q.
We expect Food Retail to make some purchases in Q4 '26 in anticipation of El Niño to make sure that our stores have enough inventory to sustain and surpass that period. Other than that, we don't think there are going to be more or shouldn't be more impact in the operations.
But it's part of what we do. We've been through other El Niño periods before, and the focus is to guarantee no business interruption and the continuity of operation through that.
Andrea Fabbri
Great, thank you, Marcelo. Let me see if we have more questions right now, 1 second.
Okay. Yes, we have another one.
Any guidance on Food Retail EBITDA margin for 2027? Given the planned pace of mass openings, should we expect further dilution or stabilization from here?
Marcelo Ramos
We're actually in the middle of the process in the budgeting process. But what I can say as of now without the final budgeting process on note is that margin should be relatively stable, honestly, in 2027.
The impact in margins that you're seeing this quarter have to do with the issues that I mentioned, which is number 1, there was a base -- we had a challenging base last year from 2 events. One, we sold a land bank asset that we had, nonproductive land bank asset that we had.
We sold that. And we also last -- during the third quarter, we started recognizing insurance income from the business interruption that we had in 2025, both of which added to about PEN 11 million.
So taking that out, the results for the third quarter would have been a 15% growth in top line with a 10% growth in adjusted EBITDA. In addition to those non extraordinary events that we had last year, we did mention and anticipated last quarter that we were seeing some pressure in costs, namely Peruvian transportation and logistic costs and also energy costs, which if you look at the energy prices in the country and inflation in the country, 1 of the drivers of inflation has been transportation and the other 1 has been energy.
And so we shouldn't expect in 2027 a dilution in EBITDA margin like the ones you saw in the third quarter. To be honest, I think EBITDA margin should remain relatively stable to what we end in 2026.
Andrea Fabbri
Thank you. At this time, I'm showing no further questions.
I would like to turn the call over to the operator.
Operator
There appear to be no further live questions at this time. I would like to turn the floor back over to Mr.
Vallejo for any closing remarks.
Juan Blanco
Thank you. In summary, the third quarter marks another period of solid execution for InRetail.
We grew revenues by 11.6% and adjusted EBITDA by 8.8%, continued to expand our footprint across all segments and further strengthened our financial position. Domestic demand in Peru remained strong during the quarter, and our multi-format platform once again demonstrated its ability to translate this favorable environment into sustainable growth.
We recognize that the El Niño phenomenon together with temporary cost pressures such as energy and payroll could pose some challenges in the coming months. However, we believe InRetail is well positioned to navigate these conditions.
Our extensive footprint and nationwide logistics platform that is difficult to replicate, a diversified portfolio and a solid balance sheet allow us to continue serving our customers throughout this period. We remain confident in our ability to continue growing our business and creating long-term value for our shareholders.
This concludes our third quarter 2026 earnings call. On behalf of the entire InRetail team, thank you for joining us today and for continued confidence in us.
Our Investor Relations team remains available to address a follow-up question -- any follow-up questions that you may have. Thank you very much.
Operator
This concludes today's conference call. You may disconnect your lines at this time.
Thank you again for your participation.
Already premium?